95 related articles for article (PubMed ID: 19909349)
1. Non-competitive interaction between raclopride and spiperone on human D-receptors in intact Chinese hamster ovary cells.
Packeu A; De Backer JP; Vauquelin G
Fundam Clin Pharmacol; 2010 Jun; 24(3):283-91. PubMed ID: 19909349
[TBL] [Abstract][Full Text] [Related]
2. Antagonist-radioligand binding to D2L-receptors in intact cells.
Packeu A; De Backer JP; Van Liefde I; Vanderheyden PM; Vauquelin G
Biochem Pharmacol; 2008 Jun; 75(11):2192-203. PubMed ID: 18436192
[TBL] [Abstract][Full Text] [Related]
3. Antagonist-D2S-dopamine receptor interactions in intact recombinant Chinese hamster ovary cells [corrected].
Packeu A; Béghin T; De Backer JP; Vauquelin G
Fundam Clin Pharmacol; 2010 Jun; 24(3):293-303. PubMed ID: 20015228
[TBL] [Abstract][Full Text] [Related]
4. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
[TBL] [Abstract][Full Text] [Related]
5. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
6. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
Seeman P; Tallerico T; Ko F
Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D2 receptor dimer formation: evidence from ligand binding.
Armstrong D; Strange PG
J Biol Chem; 2001 Jun; 276(25):22621-9. PubMed ID: 11278324
[TBL] [Abstract][Full Text] [Related]
8. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
Schetz JA; Chu A; Sibley DR
J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
[TBL] [Abstract][Full Text] [Related]
9. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
Kiss B; Horti F; Bobok A
Synapse; 2011 Jun; 65(6):467-78. PubMed ID: 20936685
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2(High) receptors on intact cells.
Seeman P
Synapse; 2008 Apr; 62(4):314-8. PubMed ID: 18241049
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
13. Investigation of cooperativity in the binding of ligands to the D(2) dopamine receptor.
Vivo M; Lin H; Strange PG
Mol Pharmacol; 2006 Jan; 69(1):226-35. PubMed ID: 16204468
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
McCormick PN; Kapur S; Seeman P; Wilson AA
Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
[TBL] [Abstract][Full Text] [Related]
15. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
16. Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges.
Seeman P; Tallerico T; Ko F; Tenn C; Kapur S
Synapse; 2002 Dec; 46(4):235-9. PubMed ID: 12373738
[TBL] [Abstract][Full Text] [Related]
17. In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone.
Sun W; Ginovart N; Ko F; Seeman P; Kapur S
Mol Pharmacol; 2003 Feb; 63(2):456-62. PubMed ID: 12527818
[TBL] [Abstract][Full Text] [Related]
18. Distinct binding patterns of [3H]raclopride and [3H]spiperone at dopamine D2 receptors in vivo in rat brain. Implications for pet studies.
Bischoff S; Gunst F
J Recept Signal Transduct Res; 1997; 17(1-3):419-31. PubMed ID: 9029505
[TBL] [Abstract][Full Text] [Related]
19. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
[TBL] [Abstract][Full Text] [Related]
20. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
Itokawa M; Toru M; Ito K; Tsuga H; Kameyama K; Haga T; Arinami T; Hamaguchi H
Mol Pharmacol; 1996 Mar; 49(3):560-6. PubMed ID: 8643097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
